128 - No Clinically Significant Drug–Drug Interactions with Co-administration of Feminizing or Masculinizing Hormone Therapy and Twice-yearly Lenacapavir PrEP in Gender-Diverse Persons

Rapid Fire Presenter(s)

• 

  Jill Blumenthal, MD MAS (she/her/hers)

  Professor
  University of California San Diego
  San Diego, CA, United States

Co-Author(s)

• MA

  Maribel Acevedo-Quinones, MD

  Centro Ararat
  San Juan, Puerto Rico
• NP

  Nittaya Phanuphak, MD, PhD

  Institute of HIV Research and Innovation – Pribta Tangerine Clinic
  Bangkok, Krung Thep, Thailand
• JH

  Juan Carlos Hinojosa, MD

  Asociación Civil Selva Amazónica
  Iquitos, Loreto, Peru
• JL

  Javier R. Lama, MD, MPH

  Director of Research
  Asociación Civil Impacta Salud y Educacion
  Lima, Lima, Peru
• 

  Michelle Cespedes, MD, MS

  Professor of Medicine
  Icahn School of Medicine at Mount Sinai; Mount Sinai Health System
  New York, NY, United States
• NN

  Nkosiphile Ndlovu, MBChB, Dip. HIV Man

  Wits RHI, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand
  Johannesburg, Gauteng, South Africa
• CB

  Carlos Brites, MD, PhD

  Complexo Hospitalar Universitário Professor Edgard Santos
  Salvador, Bahia, Brazil
• SP

  Sarah B. Puryear, MD, MPH

  Gilead Sciences, Inc.
  Foster City, California, United States
• 

  Lillian B. Brown, MD, PhD

  Director Clinical Development
  Gilead Sciences, Inc.
  Foster City, CA, United States
• CC

  Christoph C. Carter, MD, PhD

  Director, Clinical Research (MD)
  Gilead Sciences, Inc.
  Foster City, California, United States
• PA

  Priyanka Arora, PhD

  Gilead Sciences, Inc.
  Foster City, California, United States
• MI

  Marjorie Z. Imperial, PhD

  Gilead Sciences, Inc.
  Foster City, California, United States
• KE

  Kim Etchevers, MS

  Gilead Sciences, Inc.
  Foster City, California, United States
• RS

  Renu Singh, PhD, MS

  Gilead Sciences, Inc.
  Foster City, California, United States
• PW

  Pamela Wong, MPH

  Associate Director of Biostatistics
  Gilead Sciences, Inc.
  Foster City, California, United States
• OV

  Olivia T. Van Gerwen, MD, MPH

  Fellow
  University of Alabama at Birmingham
  Birmingham, Alabama, United States